Safety & Effectiveness of Nurse Performed Colonoscopies Under Supervision
Safety & Effectiveness of Nurse Performed Colonoscopies Under Supervision: A Randomized Controlled Study in Asia (NE Study)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tai Po, Hong Kong
- Combined Endoscopy Unit, ALice Ho Miu Ling Nethersole Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 1. Subjects receiving screening colonoscopy
- 2. Age ≥ 18
- 3. Informed consent
Exclusion Criteria:
- 1. Subjects have undergone colonoscopy in the past 5 years
- 2. Patients with prior colorectal surgery
- 3. Subjects with a personal history of inflammatory bowel disease, colon adenoma or cancer or family history of Familial Adenomatous Polyposis or Familial non-polyposis syndrome
- 4. Pregnant or lactating women
- 5. Lack of consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Nurse endoscopists
Colonoscopy performed by nurse endoscopists supervised by senior medical endoscopists
|
|
|
ACTIVE_COMPARATOR: Medical endoscopists
Colonoscopy performed by senior medical endoscopists
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Adenoma detection rate
Time Frame: Up to 3 months
|
Up to 3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cecal intubation RATE
Time Frame: Up to 3 months
|
Up to 3 months
|
|
Withdrawal time
Time Frame: Up to 3 months
|
Up to 3 months
|
|
Complication rate
Time Frame: Up to 3 months
|
Up to 3 months
|
|
Patients pain score
Time Frame: Up to 3 months
|
Up to 3 months
|
|
Patients overall satisfactory score
Time Frame: Up to 3 months
|
Up to 3 months
|
|
Cecal intubation TIME
Time Frame: up to 3 months
|
up to 3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.